Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
CorrectionErratum

Correction to: “Imperatorin Is a Mechanism-Based Inactivator of CYP2B6”

Drug Metabolism and Disposition April 2015, 43 (4) 570; DOI: https://doi.org/10.1124/dmd.115.060558err
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 43 no. 4 570
DOI 
https://doi.org/10.1124/dmd.115.060558err
PubMed 
25713273

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Published online February 23, 2015.

Copyright & Usage 
Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to January 2023

AbstractFullPdf
Aug 2017032
Sep 2017082
Oct 2017082
Nov 20170110
Dec 20170160
Jan 2018050
Feb 2018043
Mar 2018081
Apr 20180110
May 2018070
Jun 20180110
Jul 2018021
Aug 2018091
Sep 2018091
Oct 2018050
Nov 2018062
Dec 2018031
Jan 2019081
Feb 2019022
Mar 2019021
Apr 2019024
May 2019011
Jun 2019011
Jul 2019053
Aug 20190126
Oct 2019087
Nov 2019062
Dec 2019095
Jan 2020034
Feb 2020053
Mar 2020063
May 2020021
Jun 2020023
Jul 2020061
Aug 2020032
Sep 2020073
Oct 2020065
Nov 2020020
Dec 2020051
Jan 20210124
Feb 2021064
Mar 2021010
Apr 2021020
May 2021010
Jun 2021010
Jul 2021010
Aug 2021010
Sep 2021010
Oct 2021010
Nov 2021010
Dec 2021011
Jan 2022010
Feb 2022010
Mar 2022010
Apr 2022010
May 2022010
Jun 2022010
Jul 2022010
Aug 2022010
Sep 2022010
Oct 2022010
Nov 2022010
Dec 2022010
Jan 2023010

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 43 (4)
Drug Metabolism and Disposition
Vol. 43, Issue 4
1 Apr 2015
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Correction to: “Imperatorin Is a Mechanism-Based Inactivator of CYP2B6”
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
CorrectionErratum

Correction to: “Imperatorin Is a Mechanism-Based Inactivator of CYP2B6”

Drug Metabolism and Disposition April 1, 2015, 43 (4) 570; DOI: https://doi.org/10.1124/dmd.115.060558err

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
CorrectionErratum

Correction to: “Imperatorin Is a Mechanism-Based Inactivator of CYP2B6”

Drug Metabolism and Disposition April 1, 2015, 43 (4) 570; DOI: https://doi.org/10.1124/dmd.115.060558err
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Correction to “Dimethandrolone, a Potential Male Contraceptive Pill, is Primarily Metabolized by the Highly Polymorphic UDP-Glucuronosyltransferase 2B17 Enzyme in Human Intestine and Liver”
  • Correction to “Identification of 5-Hydroxycotinine in the Plasma of Nicotine-Treated Mice: Implications for Cotinine Metabolism and Disposition in Vivo”
  • Correction to “Does Addition of Protein to Hepatocyte or Microsomal In Vitro Incubations Provide a Useful Improvement in In Vitro-In Vivo Extrapolation Predictability?”
Show more Erratum

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics